Bronchogen
Also known as: AEDL, Ala-Glu-Asp-Leu, Bronchial Bioregulator, Lung Peptide, Taxorest, Honluten
AEDL Tetrapeptide | Bronchial Bioregulator
Overview
Bronchogen is a Khavinson bioregulator tetrapeptide (AEDL) with primary effects on the bronchopulmonary system. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson, it targets bronchial tissue and supports respiratory function. Like other Khavinson peptides, Bronchogen penetrates cell nuclei to influence gene expression related to respiratory tissue maintenance and repair.
Key benefits
- Supports bronchial tissue function
- Regulates protein synthesis in lungs
- Targets bronchopulmonary system
- Maintains respiratory epithelium
- Part of Khavinson bioregulator family
- Epigenetic mechanism of action
- Tissue-specific targeting
- Well-tolerated in research
Mechanism of action
Bronchogen works through epigenetic regulation by penetrating cell and nuclear membranes to interact with DNA and modulate gene expression in bronchial tissue. It regulates protein synthesis in bronchopulmonary cells, supporting maintenance and repair of respiratory epithelium. The tetrapeptide structure allows efficient cellular uptake and tissue-specific targeting to bronchial structures.
Molecular data
- Type
- Tetrapeptide bioregulator
- Half-life
- Minutes (short peptide); effects persist via epigenetic changes
Sequence
Ala-Glu-Asp-Leu
Indications
What the research community uses this compound for, with self-reported effectiveness.
Respiratory Support
Bronchial Function
EffectiveSupports bronchial tissue through gene expression regulation.
Respiratory Maintenance
ModerateHelps maintain respiratory epithelium health.
Pulmonary Health
ModerateRegulates protein synthesis in lung tissue.
Anti-Aging
Respiratory Aging
ModerateAddresses age-related changes in bronchial tissue.
Gene Expression
ModerateModulates gene expression in respiratory cells.
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Oral
Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Standard protocol | 10-20 mg | Daily for 10-20 days | Oral capsules |
| Maintenance | 10 mg | 2-3 cycles yearly | Oral capsules |
Injectable
Injectable form available for direct administration.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Research protocol | 10 mg | Daily for 10 days | IM or SubQ |
Preparation
You will need
- Bacteriostatic water
- Insulin syringes
- Alcohol swabs
- Sterile vial
Steps
- Clean work area thoroughly
- Reconstitute with appropriate volume
- Gently swirl until dissolved
- Store reconstituted solution refrigerated
Work out the water volume and syringe units in the reconstitution calculator →
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
Chonluten
SynergisticRelated respiratory bioregulators; complementary mechanisms.
Epitalon
SynergisticOften combined in comprehensive anti-aging Khavinson protocols.
Crystagen
CompatibleBoth have immune-modulating properties; different tissue targets.
Vilon
CompatiblePart of Khavinson bioregulator family; targets different tissue.
Timeline
Typical week-by-week effects reported in clinical and observational data.
- During cycle
Gene expression modulation begins
- Post-cycle
Effects persist due to epigenetic changes
- Weeks-Months
Respiratory function improvements
- Long-term
Cumulative benefits with periodic cycles
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Generally well-tolerated
- Minimal side effects reported
Rare side effects
- Allergic reactions (rare)
Stop signs — stop and seek advice
- Allergic reactions
- Unusual respiratory symptoms
Contraindications
- Active respiratory emergencies (seek medical care)
- Known hypersensitivity
- Pregnancy or breastfeeding
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- White powder or capsules
- Clear solution if reconstituted
- Proper packaging and labeling
Warning signs
- Unknown source or purity
Stop signs — don't use
- Discoloration
- Unusual odor
- Damaged packaging
References
Primary literature and clinical-trial data informing this entry.
Khavinson Peptide Bioregulators
Advances in Gerontology · 2020
Comprehensive review of bioregulator peptides including respiratory bioregulators.
Short Peptides and Bronchial Function
Bulletin of Experimental Biology and Medicine · 2018
Tetrapeptides derived from bronchial tissue regulate protein synthesis in respiratory cells.
Bioregulator Peptides and Respiratory Health
Cell Technologies in Biology and Medicine · 2016
Short peptides support bronchopulmonary system through epigenetic mechanisms.
Last updated . How this page was sourced is described in the methodology.